Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Determinants of DDAVP response in mild to moderate hemophilia A
NL-OMON43824Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of desmopressin in hemophilia A, sponsored by Amsterdam University Medical Center. Primary endpoints: Clinical factors determining DDAVP response, Genetic factors determining DDAVP response and 2 more. Started Feb 2013; status: active, not recruiting.
02
Drugs
desmopressin
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NL-OMON43824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43824.